Behavioral and clinical correlates of serum bilirubin concentrations in Japanese men and women

BMC Endocrine Disorders

Volumn 13, Issue , 2013, Pages

  Tanaka, Maya ^a   Budhathoki, Sanjeev ^a   Hirata, Akie ^a   Morita, Makiko ^a   Kono, Suminori ^a   Adachi, Masahiro ^a   Kawate, Hisaya ^a   Ohnaka, Keizo ^a   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Alcohol; Bilirubin; Coffee; High density lipoprotein cholesterol; Smoking

Indexed keywords

BILIRUBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; COFFEE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; SMOKING; TEA;

EID: 84884939703     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-13-39     Document Type: Article

References (36)

1. Vítek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007, 43:1-57.
2. Schwertner HA, Vítek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008, 198:1-11. 10.1016/j.atherosclerosis.2008.01.001, 18343383.
3. Abraham NG, Kappas A. Pharmacological and clinical aspects of hemo oxygenase. Pharmacol Rev 2008, 60:79-127. 10.1124/pr.107.07104, 18323402.
4. Ohnaka K, Kono S. Bilirubin, cardiovascular diseases and cancer: epidemiological perspectives. Expert Rev Endocrinol Metab 2010, 5:891-904.
5. Takayanagi R, Inoguchi T, Ohnaka K. Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. J Clin Biochem Nutr 2011, 48:72-77. 3022068, 21297916.
6. Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004, 40:827-835.
7. Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. JAMA 2011, 305:691-697. 10.1001/jama.2011.124, 21325185.
8. Van Hoydonck PG, Temme EH, Schouten EG. Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int J Epidemiol 2001, 30:1465-1472. 10.1093/ije/30.6.1465, 11821365.
9. Schwertner HA. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 1998, 136:383-387. 10.1016/S0021-9150(97)00232-3, 9543110.
10. Temme EH, Zhang J, Schouten EG, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001, 12:887-894. 10.1023/A:1013794407325, 11808707.
11. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, Ducimetière P, Patterson CC, Kee F, Yarnell JW, Evans A. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007, 14:79-84. 10.1097/01.hjr.0000230097.81202.9f, 17301631.
12. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009, 40:3422-3427. 10.1161/STROKEAHA.109.560649, 19713538.
13. Bhuiyan AR, Srinivasan SR, Chen W, Sultana A, Berenson GS. Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study. Metabolism 2008, 57:612-616. 10.1016/j.metabol.2007.12.003, 18442622.
14. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995, 41:1504-1508.
15. Ekblom K, Marklund SL, Jansson JH, Osterman P, Hallmans G, Weinehall L, Hultdin J. Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting. Circ Cardiovasc Genet 2010, 3:340-347. 10.1161/CIRCGENETICS.109.861773, 20562445.
16. Vítek L, Novotný L, Sperl M, Holaj R, Spácil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 2006, 21:408-414. 10.1159/000091966, 16534198.
17. Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vítek L, Bulmer AC, Wagner KH. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci 2013, 125:257-264. 10.1042/CS20120661, 23566065.
18. Ranheim T, Halvorsen B. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005, 49:274-284. 10.1002/mnfr.200400109, 15704241.
19. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006, 46:101-123. 10.1080/10408390500400009, 16507475.
20. Pham NM, Yoshida D, Morita M, Yin G, Toyomura K, Ohnaka K, Takayanagi R, Kono S. The relation of coffee consumption to serum uric Acid in Japanese men and women aged 49-76 years. J Nutr Metab 2010, pub ahead of print 27 Jul 2010. doi: 10.1155/2010/930757.
21. Ohnaka K, Kono S, Inoguchi T, Yin G, Morita M, Adachi M, Kawate H, Takayanagi R. Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Pract 2010, 88:103-110.
22. Tokuda K, Tanimoto K. A new method of measuring bilirubin in serum by vanadic acid (Japanese). Rinsho Kagaku 1993, 22:116-122.
23. Hirata M, Takanashi N, Oka M, Tsukada Y. Application of unsensitixed soap-free latex to a new assay principle for HbA1c and its evaluation (Japanese). Igaku-to-Yakugaku 1995, 34:125-136.
24. Barrett PV. Hyperbilirubinemia of fasting. JAMA 1971, 217:1349-1353. 10.1001/jama.1971.03190100033006, 5109641.
25. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology 1997, 113:1798-1800.
26. Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM. Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol 1989, 42:172-179. 10.1136/jcp.42.2.172, 1141821, 2921359.
27. Broughton PM, Holder R, Ashby D. Long-term trends in biochemical data obtained from two population surveys. Ann Clin Biochem 1986, 23:474-486.
28. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2003, 55:65-85.
29. Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohota T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. Journal Atheroscler Thromb 2008, 15:116-121.
30. Kannel WB, Ellison RC. Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta 1996, 15:59-76.
31. Fukushima Y, Ohie T, Yonekawa Y, Yonemoto K, Aizawa H, Mori Y, Watanabe M, Takeuchi M, Hasegawa M, Taguchi C, Kondo K. Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J Agric Food Chem 2009, 57:1253-1259. 10.1021/jf802418j, 19187022.
32. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993, 9:293-297. 10.1007/BF00146266, 8104822.
33. Cadden IS, Partovi N, Yoshida EM. Possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007, 26:1-8.
34. Ikeda M, Maki T, Yin G, Kawate H, Adachi M, Ohnaka K, Takayanagi R, Kono S. Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest 2010, 70:171-179. 10.3109/00365511003650165, 20205615.
35. Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP. Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010, 139:1699-1710. 10.1053/j.gastro.2010.06.048, 20600030.
36. Okamura S, Suzuki K, Yanase M, Koizumi M, Tamura HO. The effects of coffee on conjugation reactions in human colon carcinoma cells. Biol Pharm Bull 2005, 28:271-274. 10.1248/bpb.28.271, 15684482.